Experimental study on the anti-cerebral ischemic effect of Naoshuankang and its mechanism

张红梅,王银叶,李长龄

DOI: https://doi.org/10.3321/j.issn:1673-8225.2003.22.022

2003-01-01

Abstract:Aim: To evaluate the effect of Naoshuankang in prevention and cure of cerebral ischemia and to study its mechanism. Methods: Bilateral carotid ligation models of rats were established to test the contents of K+, Na+, H2O and MDA in brain, and examine brain tissue morphology under microscope. The hemorrheologic indexes, platelet aggregation and cerebral blood flow were measured in the model and normal rats. Results: Naoshuankang (75 mg/kg) significantly prevented K+ loss and Na+ accumulation in acute cerebral ischemic rats( P < 0.05), and ameliorated the neuronal degeneration of Hippocampus of ischemic brain tissue. The brain water and MDA contents were decreased with Naoshuankang of 150 mg/kg (P < 0.05). Administraction of 150 mg/kg and 75 mg/kg Naoshuankang obviously inhibited the platelet aggregation of the normal rats induced by ADP with the inhibitive rate of 85.6% and 72.8%, respectively. Treated with 300 mg/kg, 150 mg/kg and 75 mg/kg Naoshuankang for 5 d the platelet aggregation of the model rats were inhibited with the inhibitive rate of 62.6%, 57.3% and 32.8%, respectively. Administration of 300 mg/kg Naoshuankang increased the brain blood flow of the normal rats by 9.6% and decreased the plasma fibrinogen content of the model rats from (7.20 ± 1.49) g/L to (6.03 ± 0.88) g/L. Conclusion: Naoshuankang shows the significantly protective effect on cerebral ischemia. Its mechanism may include inhibiting platelet aggregation, decreasing plasma fibrinogen content, increasing brain blood flow and protecting cerebral cells against oxidation.